Supernus Pharmaceuticals | SUPN - Vermögenswerte

Aktienkurs
49.43
Täglich Wechseln
-1.77 -3.46%
Monatlich
0.43%
Jährlich
47.86%
Q2 Prognose
48.44




Vermögenswerte Veränderung Datum
Abbott USD 110.43B 23.72B 2026-03
ANI Pharmaceuticals USD 1.42B 18.41M 2026-03
Aurora Cannabis CAD 775.29M 18.43M 2025-12
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Canopy Growth CAD 1.11B 36.35M 2025-12
Cara Therapeutics USD 32.07M 6.95M 2025-12
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Eisai JPY 1.49T 48.22B 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Novo Nordisk DKK 559.22B 16.32B 2026-03
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Pfizer USD 207.62B 542M 2026-03
Supernus Pharmaceuticals USD 1.5B 48.08M 2026-03
United Therapeutics USD 6.71B 1.17B 2026-03
Xeris Pharmaceuticals USD 392.01M 8.49M 2026-03